Liquid Biopsy in Biliary Tract Cancer: When Tissue is Not Enough
Author(s)
Au, L; Tie, J;
Journal Title
Clinical Cancer Research
Publication Type
Online publication before print
Abstract
Circulating tumor DNA (ctDNA) profiling detects actionable genomic alterations in advanced biliary tract cancer faster (8 vs 27 days) and more often (90% vs 50%) than tissue, with high concordance. A recent retrospective study establishes clinical validity and a compelling access case for future prospective ctDNA-directed trials.
Department(s)
Medical Oncology
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2026-09-03 12:44:07
Last Modified: 2026-09-03 12:44:21
An error has occurred. This application may no longer respond until reloaded. Reload 🗙